RNAConnect, Inc. formally launches today to drive RNA analysis with innovative research tools

Research News

RNAConnect, Inc. formally launches today to drive RNA analysis with innovative research tools
RNADevelopmental BiologyGenomics
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 14 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 71%

RNAConnect, a pioneering life science reagent company, officially launches today, promising groundbreaking solutions for exploring the real-world diversity of RNA sequence and structure.

From RNA ConnectMay 29 2024

Founded by Anna Marie Pyle, PhD, Yale University Sterling Professor of Molecular, Cellular & Developmental Biology; Professor of Chemistry and Howard Hughes Medical Institute Investigator, RNAConnect exclusively licensed pioneering enzymatic technology from Yale.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

RNA Developmental Biology Genomics Life Science Medicine Reverse Transcriptase Technology

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Advancing cancer therapeutics: Development of assays for measuring RNA helicase activityAdvancing cancer therapeutics: Development of assays for measuring RNA helicase activityThis article explores advancing cancer therapeutics and the development of selective RNA helicase inhibitors.
Read more »

Advanced characterization of RNA-ligand binding dynamics through MMS technologyAdvanced characterization of RNA-ligand binding dynamics through MMS technologyThis article explores the use of MMS technology for characterization of RNA-ligand binding dynamics.
Read more »

Drug targeting RNA modifications shows promise for treating neuroblastomaDrug targeting RNA modifications shows promise for treating neuroblastomaNeuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with high-risk neuroblastoma, currently more than 40% of patients do not survive.
Read more »

Study uncovers molecular mechanism linking nonsense-mediated RNA decay to microcephalyStudy uncovers molecular mechanism linking nonsense-mediated RNA decay to microcephalyNonsense-mediated RNA decay, or NMD, is an evolutionarily conserved molecular mechanism in which potentially defective messenger RNAs, or mRNAs (genetic material that instructs the body on how to make proteins), are degraded.
Read more »

RNA editing using CRISPRs shows promise for genetic disease treatmentRNA editing using CRISPRs shows promise for genetic disease treatmentA team at Montana State University published research this week that shows how RNA, the close chemical cousin to DNA, can be edited using CRISPRs.
Read more »

Study finds that the transport of mRNAs into axons along with lysosomal vesicles prevents axon degenerationStudy finds that the transport of mRNAs into axons along with lysosomal vesicles prevents axon degenerationRNA granules, sites for the storage, transport, and regulation of RNA molecules within cells, are transported along axons and then translated locally, far from the cell body.
Read more »



Render Time: 2025-02-26 16:05:24